The kick-off trilogue on the Vital Medicines Act (CMA) came about on Monday night (2 February), with discussions described as constructive. Co-legislators reiterated each their readiness to maneuver ahead and the urgency of the file, given ongoing considerations across the EU’s safety of drugs provide.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
